september, 2020
17sep10:00- 12:30POST-PANDEMIC WORLD: WHAT INNOVATIONS AWAIT HEALTHCARE?Online
Event Details
2020 has changed the world to the point of no return - the role
Event Details
2020 has changed the world to the point of no return – the role of all things “distant” and “e” is growing exponentially every day. These new trends have already transformed and digitized learning, market sales, and sometimes even social life.
Simultaneously, the healthcare challenges of this year (including Covid19) has made even the most incredulous innovations, including innovative treatments, personalized medicine, the use of e-devices and robots a very realistic and talked about even in the most conservative circles. There is no dispute that successful innovations often possess two key qualities: they are both usable and desirable. But how can proven innovations be quickly and effectively adopted as best practice and taken up across the whole healthcare system?
Simultaneously, the healthcare challenges of this year (including Covid19) has made even the most incredulous innovations, including innovative treatments, personalized medicine, the use of e-devices and robots a very realistic and talked about even in the most conservative circles. There is no dispute that successful innovations often possess two key qualities: they are both usable and desirable. But how can proven innovations be quickly and effectively adopted as best practice and taken up across the whole healthcare system?
American Chamber of Commerce, together with Local American Working Group, invites to discuss:
- which innovations and future predictions are already needed now
- which innovations are likely to happen soon
- which innovations will have to wait
- which innovations need substantial funding from the state and other tools?
Thursday, September 17th, 2020
10:00 – 11:00 | What support is needed for the introduction of innovative treatments in healtcare? Is support needed at all?
- Mindaugas Plieskis | Head of Medical Affairs Baltics Janssen, New Ventures Lead Baltics, Johnson & Johnson Innovation
- Etienne Jousseaume | Head of Market Access Cell & Gene Europe, Novartis
11:00 – 11:30 | What are the main building elements for a crisis-resilient health institution?
- Kerry Halferty Hardy | Fellow, HITLAB Healthcare Innovation Lab
11:30 – 12:30 | Health budget planning: A cushion for surprises VS continued investments in innovation?
- Per Troein | Vice President of Strategic Partners, IQVIA, Inc.
- Rūta Pumputienė | Attorney-at-law, Head at Local American Working Group
Moderator: Eglė Markevičiūtė | Glik Agency
To RSVP, please e-mail administration@amcham.lt
Registration is free of charge. Please register no later than Wednesday, September 16th, 2020.
Registration is free of charge. Please register no later than Wednesday, September 16th, 2020.
(!) This is an online event, you will receive MS Teams link along with registration confirmation e-mail.
Time
(Thursday) 10:00 - 12:30
Location
Online